Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Recursion Pharmaceuticals, Inc.CL A(RXRX) | 5,941,120 | 5,941,120 | 0 | $40.16M | $31.43M | 36.17% | -$8.73M |
| Evolv Technologies Holdings, Inc.CL A(EVLV) | 9,681,281 | 9,681,281 | 0 | $38.24M | $30.21M | 34.76% | -$8.04M |
| Rocket Lab USA, Inc. | 1,377,943 | 1,377,943 | 0 | $35.10M | $24.64M | 28.35% | -$10.46M |
| Mind Medicine (MindMed) Inc. | 100,350 | 100,350 | 0 | $698.4K | $587.0K | 0.68% | -$111.4K |
| Roivant Sciences Ltd.SHS(ROIV) | 3,875 | 3,875 | 0 | $45.8K | $39.1K | 0.04% | -$6.7K |
| Oklo Inc.CL A(OKLO) | 5,277,513 | 0 | -5,277,513 | $112.04M | $0 | — | -$112.04M |